Soleno Therapeutics, Inc. (SLNO)
Market Closed
15 May, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
53. 01
0
0%
After Hours
$
-0 -0% 53. 01
2.76B Market Cap
- P/E Ratio
- Div Yield
4.97M Volume
-2.37 Eps
$ 53.01
Previous Close Investors:
Want to track SLNO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Soleno Therapeutics, Inc. (SLNO) Statistics
Valuation metrics
Market Cap 2.76B
Enterprise value 2.63B
Trailing P/E (ttm) 27.09
Forward P/E -23.21
PEG ratio 0.02
Price/Sales (ttm) 9.69
Price/Book (mrq) 5.57
Enterprise Value/Revenue 9.24
Enterprise Value/EBITDA 24.62
Overview
Shares outstanding 52.29M
Float 47.9M
Shares short 8.45M
% Held by insiders 0.02%
% Held by institutions 1.28%
Average volume (10 days) 4.97M
Average volume (90 days) 1.84M
Price summary
52-Week low 29.43
52-Week high 90.32
Beta -2.81
50-Day moving average 53.01
200-Day moving average 44
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:15
Last split Date 26 Aug 2022
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.34%
Operating margin 0.31%
Operational effectiveness
Return on assets 0.16%
Return on equity 0.23%
Income Statement
Revenue (ttm) 190.4M
Revenue per share (ttm) 5.47
Quarterly revenue growth (yoy) 0.39%
Gross profit (ttm) 187.7M
EBITDA 33.92M
Net income to common (ttm) 20.48M
Diluted EPS (ttm) 1.84
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 305.47M
Total cash per share (mrq) 4.91
Total debt (mrq) 52.55M
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 5.62%
Book value per share (mrq) 9.52
Cash Flow
Cash flow statement 46.8M
Levered free cash flow (LFCF) 48.27M
